tm logo

Monitor this mark

View On USPTO

SILENOR DOXEPIN TABLETS
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 15 Sep 2021

Last Applicant/ Owned by

CURRAX PHARMACEUTICALS LLC

155 Franklin Road, Suite 450

Brentwood

TN

37027

Serial Number

86714322 filed on 04th Aug 2015

Registration Number

4967840 registered on 31st May 2016

in the Principal Register

Correspondent Address

Andrew N. Spivak

Andrew N. Spivak

5185 MACARTHUR BOULEVARD, NW, SUITE 350

WASHINGTON, DC 20016-3341

Filing Basis

1. use application currently

Disclaimer

NO DATA

SILENOR DOXEPIN TABLETS

Pharmaceutical preparations for the treatment of sleep disorders comprised of doxepin

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of sleep disorders comprised of doxepin

First Use Date in General

30th Jun 2014

First Use Date in Commerce

30th Jun 2014

Mark Details

Serial Number

No 86714322

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.01.10 -

Three or more stars

01.01.12 -

More than one star with four points

01.05.01 -

Sun, rising or setting (partially exposed or partially obstructed)

Legal History

Show more

Status DateAction Taken
15th Sep 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
15th Sep 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15th Sep 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
27th Jul 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27th Jul 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
27th Jul 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27th Jul 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27th Jul 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
31st May 2021TEAS SECTION 8 & 15 RECEIVED
31st May 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED